American Regent, Inc.
Quick facts
Marketed products
- Ferric Carboxymaltose (FCM) · Hematology
Ferric carboxymaltose delivers iron directly into the bloodstream as a stable iron-carbohydrate complex that is taken up by iron-binding proteins to replenish depleted iron stores. - Ferrous Sulfate tablets
- Iron Sucrose (Venofer) · Hematology
Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and treat iron deficiency anemia. - Tralement · Other
- Venofer® 200 mg
Phase 3 pipeline
- Iron Sucrose + Erythropoietin · Hematology / Nephrology
Iron sucrose replenishes iron stores while erythropoietin stimulates red blood cell production to treat anemia in patients with chronic kidney disease. - iron sucrose injection USP · Hematology
Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and support hemoglobin synthesis in patients with iron deficiency. - Oral Iron + Erythropoietin · Hematology
This combination therapy replaces iron stores to support hemoglobin synthesis while erythropoietin stimulates red blood cell production to treat anemia. - stable erythropoietin therapy · Hematology
Stable erythropoietin therapy works by stimulating the production of red blood cells. - Standard Medical Care (SMC)
Standard Medical Care (SMC) is a treatment that does not involve a specific mechanism of action. - VIT-45 · Immunology
VIT-45 is a vitamin D analog that enhances immune function and reduces inflammation through vitamin D receptor signaling.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about American Regent, Inc.
What are American Regent, Inc.'s marketed drugs?
Top marketed products include Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets, Iron Sucrose (Venofer), Tralement, Venofer® 200 mg.
What is American Regent, Inc.'s pipeline?
American Regent, Inc. has 6 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Iron Sucrose + Erythropoietin, iron sucrose injection USP, Oral Iron + Erythropoietin, stable erythropoietin therapy.
Related
- Ferric Carboxymaltose (FCM) · Hematology
- Ferrous Sulfate tablets
- Iron Sucrose (Venofer) · Hematology
- Tralement · Other
- Venofer® 200 mg
- Sector hub: All tracked pharma companies